Processing

Please wait...

Settings

Settings

1. WO2009150623 - TREATMENT OF CHRONIC PROSTATITIS

Publication Number WO/2009/150623
Publication Date 17.12.2009
International Application No. PCT/IB2009/052482
International Filing Date 10.06.2009
IPC
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
22
against growth factors
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
395
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13
Drugs for disorders of the urinary system
08
of the prostate
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13
Drugs for disorders of the urinary system
10
of the bladder
C07K 16/22 (2006.01)
A61K 39/395 (2006.01)
A61P 13/08 (2006.01)
A61P 13/10 (2006.01)
CPC
A61K 2039/505
C07K 16/22
C07K 2317/24
C07K 2317/55
C07K 2317/565
C07K 2317/567
Applicants
  • PFIZER INC [US/US]; 235 East 42nd Street New York, New York 10017, US (AllExceptUS)
  • SHELTON, David Louis [US/US]; US (UsOnly)
Inventors
  • SHELTON, David Louis; US
Agents
  • KLEIMAN, Gabriel L.; Pfizer Inc. 235 East 42nd Street New York, New York 10017, US
Priority Data
61/061,14113.06.2008US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TREATMENT OF CHRONIC PROSTATITIS
(FR) TRAITEMENT DE LA PROSTATITE CHRONIQUE
Abstract
(EN)
The present invention relates to the use of an anti-NGF antibody in the treatment or prevention of pain and/or a lower urinary tract symptom (LUTS) associated with chronic prostatitis and/or chronic pelvic pain syndrome.
(FR)
La présente invention concerne l'utilisation d'un anticorps anti-NGF dans le traitement ou la prévention de la douleur et/ou d'un symptôme du bas appareil urinaire (LUTS) associé(e) à une prostatite chronique et/ou un syndrome de douleur pelvienne chronique.
Latest bibliographic data on file with the International Bureau